AstraZeneca: Leading bank bullish after key conference appearance

JP Morgan has maintained its bullish stance on AstraZeneca PLC (LSE:AZN) in the wake of the San Francisco healthcare conference it sponsors. Repeating its overweight stance £130 a share price target, the US bank provided its assessment of a Q&A session fronted by AZ's CFO Aradhana Sarin, which presented a robust outlook for the company. Sarin focused on the potential of the drug giant's pipeline, which includes the intention to launch 15 new therapies by the end of the decade. This prospective contribution ...